Aimmune shareholders accept $2 billion Nestle tender offer

This post was originally published on this site

https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG9C0AY_L.jpg

Including shares it already held, Nestle controlled around 84% of the outstanding shares as of the $34.50 per share offer’s expiration date. “The minimum tender condition to the consummation of the offer set forth in the offer to purchase has been satisfied,” Nestle said.